Holen Sie sich die Stockscreener-App
1.57
1.54%
-0.03
Schlusskurs vom Vortag:
$1.60
Offen:
$1.52
24-Stunden-Volumen:
554.34K
Relative Volume:
2.31
Marktkapitalisierung:
$7.19M
Einnahmen:
$895.50K
Nettoeinkommen (Verlust:
$-26.30M
KGV:
-0.9573
EPS:
-1.64
Netto-Cashflow:
$-23.84M
1W Leistung:
-3.94%
1M Leistung:
-5.10%
6M Leistung:
-52.69%
1J Leistung:
-89.53%
1-Tages-Spanne:
$1.50
$1.64
1-Wochen-Bereich:
$1.2801
$1.75
52-Wochen-Spanne:
$1.2801
$16.04
Mainz Biomed N V Stock (MYNZ) Company Profile
Firmenname
Mainz Biomed N V
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MYNZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
1.57 | 8.66M | 895.50K | -26.30M | -23.84M | -1.64 |
|
TMO
Thermo Fisher Scientific Inc
|
531.81 | 202.47B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
203.99 | 146.76B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
629.10 | 50.40B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
139.35 | 39.92B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
202.57 | 34.10B | 15.70B | 1.24B | 2.01B | 6.9036 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-14 | Eingeleitet | Maxim Group | Buy |
| 2024-11-25 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Mainz Biomed N V Aktie (MYNZ) Neueste Nachrichten
Relative strength of Mainz Biomed N.V. in sector analysisMarket Activity Summary & Expert Verified Stock Movement Alerts - newser.com
Will Mainz Biomed N.V. (4TO) stock benefit from mergersJuly 2025 Reactions & Long-Term Growth Plans - newser.com
How Mainz Biomed N.V. (4TO) stock expands through international marketsMarket Rally & Verified Chart Pattern Signals - newser.com
What drives Mainz Biomed NV stock priceMarket Entry Points & Free Stock Predictions and Analysis - earlytimes.in
Mainz Biomed (NASDAQ:MYNZ) Trading Down 3% – Here’s What Happened - Defense World
Mainz Biomed (NASDAQ:MYNZ) Trading Down 3% – What’s Next? - Defense World
How forex fluctuations impact Mainz Biomed N.V. (4TO) stock2025 Market Sentiment & Breakout Confirmation Alerts - newser.com
Mainz Biomed reports promising results for pancreatic cancer blood test By Investing.com - Investing.com Nigeria
Mainz Biomed reports promising results for pancreatic cancer blood test - Investing.com India
Mainz Biomed N.V. Reports Positive Results from Feasibility Study for Non-Invasive Pancreatic Cancer Screening Test - Quiver Quantitative
100% sensitivity: Mainz Biomed biomarker panel shows 95% specificity in 30‑patient pancreatic study - Stock Titan
What analysts say about Mainz Biomed NV stockMarket Correction Analysis & Outstanding Profit Strategies - earlytimes.in
Can Mainz Biomed N.V. recover in the next quarter2025 Analyst Calls & Verified Entry Point Detection - newser.com
Visual analytics tools that track Mainz Biomed N.V. performanceInsider Selling & AI Forecasted Stock Moves - newser.com
What MACD and RSI say about Mainz Biomed N.V.CPI Data & High Return Stock Watch Alerts - newser.com
Real time breakdown of Mainz Biomed N.V. stock performance2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com
Real time pattern detection on Mainz Biomed N.V. stockSell Signal & Daily Growth Stock Tips - newser.com
Can swing trading help recover from Mainz Biomed N.V. lossesJuly 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
How Mainz Biomed N.V. (4TO) stock reacts to monetary easingTrade Volume Summary & Weekly High Momentum Picks - newser.com
Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting - GlobeNewswire
97% Accuracy: Mainz Biomed's Revolutionary RNA Test Could Transform Early Colorectal Cancer Detection - Stock Titan
Published on: 2025-09-30 00:50:22 - newser.com
Can Mainz Biomed N.V. (4TO) stock double in coming yearsQuarterly Trade Report & Weekly Momentum Picks - newser.com
Finanzdaten der Mainz Biomed N V-Aktie (MYNZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.19%
1.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):